EDWARDS LIFESCIENCES CORP (EW) Stock Price, Quote, News and Summary
NYSE:EW - New York Stock Exchange, Inc. - US28176E1082 - Common Stock
EW Quote and Key Statistics
EDWARDS LIFESCIENCES CORP
NYSE:EW (1/21/2025, 8:04:00 PM)
After market: 69.97 0 (0%)69.97
+0.19 (+0.27%)
EW Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 73.98% | ||
| ROA | 32.06% | ||
| ROE | 43.57% | ||
| Debt/Equity | 0.06 |
EW Performance and Technical Analysis
EW Ownership and Analysts
EW Latest News and Analysis
Monday's pre-market session: top gainers and losers in the S&P500 index
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Morgan Stanley Promotes Mahdavi, Teasdale to Run Americas M&A
Morgan Stanley has promoted Lily Mahdavi and Ben Teasdale to co-lead its mergers and acquisitions team in the Americas, according to a person familiar with the situation.
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
About EW
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 19,800 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). The company develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.
Company Info
EDWARDS LIFESCIENCES CORP
One Edwards Way
Irvine CALIFORNIA 92614 US
CEO: Michael A. Mussallem
Employees: 19800
Company Website: https://www.edwards.com
Investor Relations: https://ir.edwards.com/
Phone: 19492502500
EW Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 89.9 | 215.18B | ||
| ABT | ABBOTT LABORATORIES | 25.84 | 202.57B | ||
| SYK | STRYKER CORP | 34.01 | 150.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.76 | 148.72B | ||
| MDT | MEDTRONIC PLC | 16.83 | 113.33B | ||
| BDX | BECTON DICKINSON AND CO | 18.27 | 69.71B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.7 | 39.90B | ||
| RMD | RESMED INC | 29.89 | 36.38B | ||
| IDXX | IDEXX LABORATORIES INC | 39.03 | 34.99B | ||
| DXCM | DEXCOM INC | 50.78 | 33.72B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.98 | 24.97B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 14.01 | 22.00B |